SUBSCRIBE
SUBSCRIBE

Alloy Therapeutics

NEWS
Business
Newly-Launched Normunity Becomes Alloy’s Latest Partner in IO Deal
Alloy Therapeutics inked an antibody discovery deal with Normunity Thursday to advance the latter’s immune normalizers, antibody therapies that boost the body’s natural immune system to fight cancer.
November 17, 2022
 · 
1 min read
 · 
Rosemary Scott
male hands with wrist watch is considered American dollars. Hands holding dollar cash. 1000 dollars in 100 bills in a man's hand close-up on a dark background. hundred
Business
Money on the Move: EnPlusOne, Cellarity, Voyager and More
Funding rounds this week saw money flow into innovative drug discovery and delivery platforms, while pharma powerhouse Pfizer wrapped up two high-value neuro deals.
October 5, 2022
 · 
5 min read
 · 
Tristan Manalac
JOBS
IN THE PRESS
Press Releases
Alloy Therapeutics Announces Acquisition of Spannerwerks, a Leading Provider of Drug Development Consulting Services
October 24, 2025
 · 
3 min read
Press Releases
Alloy Therapeutics and University of British Columbia Partner to Accelerate Antibody Discovery with Cryo-Electron Microscopy Technology
October 8, 2025
 · 
3 min read
Press Releases
Alloy Therapeutics and Kansai Startup Academia Coalition (KSAC) Announce Strategic Collaboration to Accelerate Global Growth of Japanese Life Science Startups
July 23, 2025
 · 
4 min read
Press Releases
Alloy Therapeutics Enters Japanese Market by Establishing Operations at Shonan Health Innovation Park
May 22, 2025
 · 
3 min read
Press Releases
MultiOmic Health and Alloy Therapeutics Collaborate to Discover and Develop Renal Tissue-Targeting Drugs
April 2, 2025
 · 
4 min read
Press Releases
Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer to Develop New Antibody Discovery Platform
February 12, 2025
 · 
3 min read
Press Releases
Ypsilon Receives $2.7 Million Non-Dilutive Grant to Advance Next-Generation TCRm Antibodies
January 30, 2025
 · 
4 min read
Press Releases
Alloy Therapeutics Announces New Licensing Model for ATX-Gx™ Antibody Discovery Platform and Launches mAbForge™ High-Throughput Screening Service
January 9, 2025
 · 
2 min read
Press Releases
Alloy Therapeutics Announces a Target Specific Collaboration and License Agreement for use of AntiClastic™ Antisense Platform with Sanofi
January 8, 2025
 · 
4 min read
Press Releases
Alloy Therapeutics Signs Collaboration and License Agreement with Takeda to Develop Cell Therapy Platform
November 21, 2024
 · 
4 min read
Load More